Transfection Reagents and Equipment Market – Global Leaders and Growth Strategies Adopted by Them
The global growth of the transfection reagent market can be attributed to factors such as advancements in transfection technology, global alliances among leading research institutes to trigger drug discovery, increase in R&D spending and research activities by pharmaceutical and biotechnology companies, increase in demand for synthetic genes, and rising incidence of cancer.
Moreover, development...
Transfection Reagents and Equipment Market – Emerging Industry Dynamics | Global Future Forecasts
This report aims to provide insights into the global Transfection
Reagents and Equipment Market. Details on regional markets for these segments
are also presented in this report. In addition, leading players in the market
are profiled to study their product offerings and understand the strategies
undertaken by them to be competitive in this market.
Target Audience for this Report:# Biopharmaceutical...
Transfection Reagents and Equipment Market worth 1.02 Billion USD by 2021
This report studies the global transfection reagents and equipment market from 2016 to 2021. This market is expected to reach USD 1.02 Billion by 2021 from USD 715.4 Million in 2016, at a CAGR of 7.5% during the forecast period.
The global transfection reagents and equipment market is segmented on the basis of product, method, application, end user, and region.
Based on Product, the transfection reagents...
Thermo Fisher Scientific Inc. to Dominate the Global Transfection Reagents and Equipment Market
The key players in this market are continuously striving to gain larger shares and expand their existing product portfolios by agreements, collaborations, and partnerships.
The overall market was dominated by Thermo Fisher Scientific Inc. (U.S.), Promega Corporation (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), and QIAGEN N.V. (Netherlands). Other players include Polyplus-transfection SA (France),...